APRE

Aprea Therapeutics Stock Price

4.65
0.10 (2.2%)
4.65

Low
3.88

52 Week Range

High
41.115

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Aprea Therapeutics Inc APRE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 2.2% 4.65 16:10:14
Open Price Low Price High Price Close Price Prev Close
4.60 4.44 4.66 4.63 4.55
Bid Price Ask Price Spread News
4.58 4.63 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,424 465,798 $ 4.58 $ 2,132,854 5,290,477 3.88 - 41.115
Last Trade Time Type Quantity Stock Price Currency
16:23:40 1 $ 4.60 USD

Aprea Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 98.52M 21.19M 18.54M $ - $ - -2.54 -1.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.23M 3.40%

more financials information »

Aprea Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APRE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.047.804.425.3529,587,698-0.39-7.74%
1 Month4.117.804.005.338,152,0590.5413.14%
3 Months4.907.803.885.263,230,758-0.25-5.1%
6 Months25.9728.39393.885.502,406,329-21.32-82.09%
1 Year36.9041.1153.886.661,261,302-32.25-87.4%
3 Years15.4653.113.888.25778,542-10.81-69.92%
5 Years15.4653.113.888.25778,542-10.81-69.92%

Aprea Therapeutics Description

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).


Your Recent History
NASDAQ
APRE
Aprea Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.